BACKGROUND Percutaneous closure of patent ductus arteriosus (PDA) with Amplatzer duct occluder (ADO) has become increasingly popular in many cardiovascular centres. This study analysed the long-term results of percutaneous closure of PDA with ADO in a single centre. MATERIALS AND METHODS Between May 2004 and January 2013, 243 patients with median age of 2.5 years (range = 30 months to 38 year...

AIM To compare polytetrafluoroethylene stent graft (PTFE) with sirolimus and bare metal stents in reducing in-stent restenosis in native coronary vessels in patients with acute coronary syndrome. METHODS The study included patients who underwent stent implantation in acute coronary syndrome from January 2003 to May 2004. The patients (n=119) were randomized either to stent graft group (n=40),...

Unlike what was observed with brachytherapy,1 the use of drug-eluting stents (DES) has not been associated with the delayed intimal proliferation that characterises restenosis. A 12-month followup is recommended to define the need for revascularisation in DES.2 Restenosis 1 year after the implant is considered unusual. We present the case of a 77-year-old hypertensive male ex-smoker with diabet...

After alerts on Endovascular Aneurysm Seal (EVAS) failure were raised, the European Society for Vascular Surgery (ESVS) Abdominal Aortic (AAA) Clinical Practice Guidelines Writing Committee (WC) initiated a task force with aim to provide guidance surveillance and management of patients implanted EVAS devices. Based scoping review risk late serious aortic-related adverse events in treated AAA, E...